Solutions & treatments
Skin weakened by diseases and long-term treatments isn’t like other skin. So BIODERMA innovated with two products formulated to soothe skin and the imbalances caused by chemotherapy, diabetes and dialysis.
In most cases, side effects include intense itchiness and discomfort. Atoderm Xereane and Cicabio Restor contain three pure molecules that strengthen the skin’s resistance. Their formula also includes AntalgicineTM, a complex patented by Bioderma that soothes feelings of discomfort and itchiness.
Daily care for all patients who suffer from dry skin, tightness, feelings of discomfort, and itching caused by chemotherapy, dialysis or diabetes.
D-Panthenol, naturally present in the skin, is used here for its moisturising properties, which help the skin strengthen its protective barrier function. Enriched with jojoba wax and shea oil, and rich in saturated acids, Atoderm Xereane nourishes skin intensely and lastingly.
Weakened skin cannot risk intolerance, and needs proven effectiveness. Atoderm Xereane was clinically tested over 28 days on 40 patients undergoing chemotherapy, to evaluate its safety and how it affected weakened skin1.
After 28 days of product application, 95% of patients experienced improvement of skin changes. The product was well tolerated by 100% of subjects. Furthermore, the application of Atoderm Xereane led to an improvement of 80% in the quality of life1.
1. An observational, prospective and multicentric study with two visits (D0,D28). 40 subjects were included by eight investigating oncologists, 2019.
This dermo-cosmetic soothing cream provides care especially for patients undergoing chemotherapy or radiation therapy, or who have had surgery. It reduces superficial skin irritation and feelings of discomfort and helps skin to repair itself.
D-Panthenol and hyaluronic acid are naturally present in skin. Known to help moisturising, these two active ingredients are used here in concentrations that help skin to repair itself. Capryloyl glycine is another active ingredient, an antibacterial agent, that protects the skin.
Cicabio Restor’s performance and tolerance were measured during a 28-day clinical study on 34 patients suffering from irritation on hand and feet linked to their chemotherapy1
After 28 days, 78% of patients experienced an improvement of their skin barrier. The tolerance was judged by subject themselves and the product was well tolerated by 100% of them. Furthermore, Cicabio Restor led to an improvement of 80% in quality of life2.
2. A multicenter, double blind, prospective, randomized controlled (1:1 ratio) study with three visits (D0, D7, D28) involving 70 subjects included by eight oncologists, 2019.
Practical to use right up until the tube is empty, TubairlessTM packaging has an anti-reflux system. Ambient air can’t enter the tube, minimising the risk of bacterial contamination and guaranteeing maximum safety for patients.
